Literature DB >> 1407019

Evidence for a link between specific proteolysis and inhibition of [3H]-noradrenaline release by the light chain of tetanus toxin.

D Sanders1, E Habermann.   

Abstract

The light chain of tetanus toxin is known to inhibit the Ca(2+)-evoked release of [3H]-noradrenaline from digitonin-permeabilized bovine adrenomedullary cells in culture but does not change the basal outflow or the total cellular radioactivity. Evidence for the involvement of proteolysis in this effect was obtained by three approaches. First, the permeabilized cells were exposed to a series of enzymes. The endoproteinase Glu-C mimicked the inhibition produced by the light chain. Second, protease inhibitors of different specificities were assessed for blockade of the action of light chain on [3H]-noradrenaline release from permeabilized cells. Blockade was complete with EDTA (2.5 mmol/l) or 1,10-o-phenanthroline (1 mmol/l), and absent with the highest concentrations tested of diisopropylfluorophosphate, phenylmethylsulfonyl fluoride, pepstatin, leupeptin, bestatin, phosphoramidon, thiorphan or trans-epoxysuccinic acid (E64) which is regarded as an inhibitor of thiol proteases. This inhibitor spectrum suggested that light chain might be a metalloprotease. Finally a sequence-His-Glu-Leu-X-His-occurring in the light chains of tetanus toxin and of the botulinum neurotoxins A, C, D, E was also found in many endoproteinases and an aminopeptidase. The motif is known to constitute their active site and to bind Zn2+. In fact Zn2+ (0.6-0.9 mol/mol) was found in thoroughly dialysed two-chain tetanus toxin. The three approaches jointly support the hypothesis that the light chain of tetanus toxin, and probably of all clostridial neurotoxins, inhibits [3H]-noradrenaline release from adrenomedullary cells by degradation of (a) specific, still unknown protein(s) involved in exocytosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407019     DOI: 10.1007/bf00173552

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

1.  Comparison of the structures of carboxypeptidase A and thermolysin.

Authors:  W R Kester; B W Matthews
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

2.  Tetanus toxin: biochemical and pharmacological comparison between its protoxin and some isotoxins obtained by limited proteolysis.

Authors:  U Weller; F Mauler; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

3.  Amino acid sequence of a Crotalus atrox venom metalloproteinase which cleaves type IV collagen and gelatin.

Authors:  J D Shannon; E N Baramova; J B Bjarnason; J W Fox
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

4.  Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum.

Authors:  D A Boroff; U Fleck
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

5.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

Authors:  I E Collier; S M Wilhelm; A Z Eisen; B L Marmer; G A Grant; J L Seltzer; A Kronberger; C S He; E A Bauer; G I Goldberg
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

6.  The tetanus toxin light chain inhibits exocytosis.

Authors:  G Ahnert-Hilger; U Weller; M E Dauzenroth; E Habermann; M Gratzl
Journal:  FEBS Lett       Date:  1989-01-02       Impact factor: 4.124

Review 7.  Alpha 2-macroglobulin.

Authors:  A J Barrett
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

8.  Amino acid sequence deduced from a rat kidney cDNA suggests it encodes the Zn-peptidase aminopeptidase N.

Authors:  V M Watt; C C Yip
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

9.  The complete amino acid sequence of the Clostridium botulinum type-E neurotoxin, derived by nucleotide-sequence analysis of the encoding gene.

Authors:  S M Whelan; M J Elmore; N J Bodsworth; T Atkinson; N P Minton
Journal:  Eur J Biochem       Date:  1992-03-01

10.  Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.

Authors:  U Eisel; W Jarausch; K Goretzki; A Henschen; J Engels; U Weller; M Hudel; E Habermann; H Niemann
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  7 in total

1.  Es kann die Spur von unseren Erdetagen--on pharmacologists and pharmacology.

Authors:  Klaus Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11       Impact factor: 3.000

2.  Pore formation by tetanus toxin, its chain and fragments in neuronal membranes and evaluation of the underlying motifs in the structure of the toxin molecule.

Authors:  J Beise; J Hahnen; B Andersen-Beckh; F Dreyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

3.  Protein kinase C and clostridial neurotoxins affect discrete and related steps in the secretory pathway.

Authors:  M A Bittner; R W Holz
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046

4.  Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells.

Authors:  E Erdal; F Bartels; T Binscheck; G Erdmann; J Frevert; A Kistner; U Weller; J Wever; H Bigalke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

5.  Acidification of the cytosol inhibits the uptake of tetanus toxin in NG108-15 and NBr-10A neurohybridoma cells.

Authors:  H J Kalz; H H Wellhöner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-05       Impact factor: 3.000

Review 6.  The zinc-dependent protease activity of the botulinum neurotoxins.

Authors:  Frank J Lebeda; Regina Z Cer; Uma Mudunuri; Robert Stephens; Bal Ram Singh; Michael Adler
Journal:  Toxins (Basel)       Date:  2010-05-07       Impact factor: 4.546

7.  Clostridial neurotoxins compromise the stability of a low energy SNARE complex mediating NSF activation of synaptic vesicle fusion.

Authors:  L L Pellegrini; V O'Connor; F Lottspeich; H Betz
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.